View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
PerkinElmer|8 June 2022

Drug Discovery

Drug discovery starts with an understanding of the basics of diseases and disease pathways. Throughout the process of unraveling the complexity of disease pathways, identifying and characterizing targets, high throughput screening, and lead optimization PerkinElmer has the assays you can count on.

Drug discovery starts with an understanding of the basics of diseases and disease pathways. Throughout the process of unraveling the complexity of disease pathways, identifying and characterizing targets, high throughput screening, and lead optimization PerkinElmer has the assays you can count on.

PerkinElmer’s drug discovery reagents and instrumentation cover a wide array of applications ranging from immunoassays platforms and kinase assays to reporter gene, cytotoxicity, cell proliferation and high content screening assays. Our easy-to-use platforms provide greater sensitivity, wide dynamic range, and reduced background.

From basic science to high throughput screening and lead optimization, PerkinElmer drug discovery tools provide easy-to-use next generation assays every step of the way.

Extractables and leachables studies are critical for maintaining the quality of your drug product during drug development and final batch release in accordance with GMP...
The FDA defines data integrity as “completeness, consistency, and accuracy of data. Complete, consistent, and accurate data should be attributable, legible, contemporaneously recorded, original or...
Globalization of the pharmaceutical industry has led to increasing demands on regulatory agencies across the globe to ensure the quality, safety, and effectiveness of medicines.
When a new drug is first developed by a pharmaceutical company, it is initially sold under a brand name and the product is covered under...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology